机器人辅助腹腔镜手术治疗深部浸润型子宫内膜异位症

目的探讨机器人辅助腹腔镜治疗深部浸润型子宫内膜异位症的安全性及可行性。方法回顾性分析2015年3月~2019年1月行达芬奇机器人辅助腹腔镜手术治疗深部浸润型子宫内膜异位症9例的临床资料,其中输尿管浸润型1例,膀胱浸润型2例,直肠浸润型6例。结果9例均顺利完成机器人辅助腹腔镜手术,1例行输尿管狭窄段切除+端端吻合+双J管置入,术后12周拔除双J管;2例行部分膀胱切除+膀胱修补;2例行部分直肠切除+端端吻合;4例行部分直肠前壁切除+直肠修补。围手术期均无严重并发症。术后辅助3~6次亮丙瑞林3.6 mg皮下注射。术后随访10~14个月,9例临床症状均消失,无复发。结论机器人辅助腹腔镜手术治疗深部浸润型子宫内膜异位症安全可行。

Robot-assisted Laparoscopy for Deep Infiltrating Endometriosis

Objective To evaluate the safety and feasibility of robot-assisted laparoscopy for deep infiltrating endometriosis(DIE).Methods Clinical data of 9 cases who underwent da Vinci robot-assisted laparoscopy of DIE between March 2015 and January 2019 were analyzed retrospectively,including 1 case of ureteral infiltration,2 cases of bladder infiltration and 6 cases of rectal infiltration.Results The robot-assisted operations were successfully completed in all the 9 cases.The ureteral stricture resection and end-to-end anastomosis was performed in 1 case,and the double J tube was indwelled during surgery and extracted at 12 weeks postoperatively.The partial cystectomy and bladder repair was performed in 2 cases,partial rectum resection and end-to-end anastomosis was performed in 2 cases,and partial resection of the anterior wall of the rectum and rectum repair in 4 cases.There were no serious complications during the perioperative period.All the cases were given leuperirin acetate injection 3.6 mg subcutaneously for 3-6 times postoperatively.The patients were followed up for 10-14 months,and the clinical symptoms of all the 9 patients disappeared without recurrence.Conclusion Robot-assisted laparoscopy for DIE is safe and feasible.